Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Sell

C

Standard BioTools Inc. Common Stock (LAB)

Laboratory Analytical Instruments

https://www.standardbio.com

Standard BioTools Inc manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. The company's segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

2 TOWER PLACE, SUITE 2000
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/10/2011

Market Cap

671,788,740

Shares Outstanding

289,460,000

Weighted SO

289,464,031

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

STRRP --.--%

GTH --.--%

BDSX --.--%

NDRA --.--%

OLK --.--%

FONR --.--%

MDXH --.--%

NOTV --.--%

Beta

1.6710

Last Div

0.0000

Range

1.21-3.16

Chg

0.0100

Avg Vol

3365435

Mkt Cap

671788740

Exch

NASDAQ

Country

US

Phone

650 266 6000

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

4.9288

EV Multiple

-4.9885

P/FV

1.3207

Div Yield %

0.0000

P/E

-5.6800

PEG

-0.0926

Payout

0.0000

Current Ratio

3.8772

Quick Ratio

3.5330

Cash Ratio

2.1793

DSO

86.8743

DIO

213.9899

Op Cycle

300.8642

DPO

63.1154

CCC

237.7488

Gross Margin

0.4667

Op Margin

-0.8569

Pretax Margin

-0.8700

Net Margin

-0.8705

Eff Tax Rate

-0.0006

ROA

-0.1674

ROE

-0.4241

ROCE

-0.1997

NI/EBT

1.0006

EBT/EBIT

1.0152

EBIT/Rev

-0.8569

Debt Ratio

0.0860

D/E

0.1194

LT Debt/Cap

0.0006

Total Debt/Cap

0.1067

Int Coverage

-50.3236

CF/Debt

-2.0842

Equity Multi

1.3890

Rec Turnover

4.2015

Pay Turnover

5.7831

Inv Turnover

1.7057

FA Turnover

1.8394

Asset Turnover

0.1923

OCF/Share

-0.3411

FCF/Share

-0.3510

Cash/Share

1.0601

OCF/Sales

-0.9318

FCF/OCF

1.0291

CF Coverage

-2.0842

ST Coverage

-2.0945

CapEx Coverage

-34.3148

Div&CapEx Cov

-34.3148

P/BV

1.3207

P/B

1.3207

P/S

4.9288

P/E

-5.6800

P/FCF

-5.1399

P/OCF

-5.3065

P/CF

-5.3065

PEG

-0.0926

P/S

4.9288

EV Multiple

-4.9885

P/FV

1.3207

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 19, 03:51 NVIDIA Unveils NVLink Fusion for Industry to Build Semi-Custom AI Infrastructure With NVIDIA Partner Ecosystem Benzinga May 18, 20:06 CoreWeave, Super Micro Computer And Coinbase Are Among Top 11 Large-Cap Gainers Last Week (May 12-May 16): Are The Others In Your Portfolio? GlobeNewswire Inc. Apr 07, 19:00 MESA LABS DECLARES QUARTERLY DIVIDEND Benzinga Jan 27, 23:06 7 AI Infrastructure Stocks Plunge Over 20%, Outpace Semiconductor Rout As DeepSeek Upends Investment Landscape GlobeNewswire Inc. Jan 09, 23:30 Astera Labs Announces Conference Call to Review Fourth Quarter 2024 Financial Results GlobeNewswire Inc. Nov 22, 22:00 Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess GlobeNewswire Inc. Nov 04, 22:45 Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange GlobeNewswire Inc. Jul 16, 04:32 argenx and Zai Lab Announce Approval of Efgartigimod Alfa - GlobeNewswire Benzinga Jan 16, 09:49 Dow Dips 200 Points; Goldman Sachs Earnings Top Views GlobeNewswire Inc. Jan 16, 08:30 ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology GlobeNewswire Inc. Jan 08, 08:30 Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue The Motley Fool Jan 07, 10:00 Why Photronics Rocketed 48.5% Higher in December The Motley Fool Jan 07, 10:00 Why Photronics Rocketed 48.5% Higher in December The Motley Fool Jan 07, 10:00 Why Photronics Rocketed 48.5% Higher in December The Motley Fool Jan 07, 10:00 Why Photronics Rocketed 48.5% Higher in December The Motley Fool Jan 07, 10:00 Why Photronics Rocketed 48.5% Higher in December The Motley Fool Jan 07, 10:00 Why Photronics Rocketed 48.5% Higher in December The Motley Fool Jan 07, 10:00 Why Photronics Rocketed 48.5% Higher in December The Motley Fool Jan 07, 10:00 Why Photronics Rocketed 48.5% Higher in December The Motley Fool Jan 07, 10:00 Why Photronics Rocketed 48.5% Higher in December

Revenue Product Segmentation